Trial Profile
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 May 2020
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacodynamics
- 13 May 2020 Primary endpoint (Change from Baseline in Prolongation and normalization of rectal MEP and anal MEP at 10 weeks.) has been met, as per Results published in the Alimentary Pharmacology and Therapeutics
- 13 May 2020 Primary endpoint (Change from baseline in Prolongation and normalization of anal CEP and rectal CEP responses at 10 weeks.) has been met, as per Results published in the Alimentary Pharmacology and Therapeutics
- 13 May 2020 Results published in the Alimentary Pharmacology and Therapeutics